Literature DB >> 14479888

Haemophilia in Sweden. VI. Treatment of haemophilia A with the human antihaemophilic factor preparation (fraction I--0).

I M NILSSON, M BLOMBACK, O RAMGREN.   

Abstract

Entities:  

Keywords:  SERUM GLOBULIN/therapy

Mesh：

Substances：

Year:  1962        PMID： 14479888

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN： 0365-463X


× No keyword cloud information.
  5 in total

1.  Markers of Blood Cell Activation and Complement Activation in Factor VIII and von Willebrand Factor Concentrates.

Authors:  Martin F Brodde; Beate E Kehrel
Journal:  Transfus Med Hemother       Date:  2010-07-14       Impact factor: 3.747

2.  Surgery of hemophiliacs--20 years' experience.

Authors:  I M Nilsson; U Hedner; A Ahlberg; S A Larsson; S E Bergentz
Journal:  World J Surg       Date:  1977-01       Impact factor: 3.352

3.  The use of blood components in the treatment of congenital coagulation disorders.

Authors:  I M Nilsson; S A Larsson; S E Bergentz
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

Review 4.  [The role of self-infusion treatment for the patient with haemophilia (author's transl)].

Authors:  K Schimpf
Journal:  Blut       Date:  1978-02

Review 5.  Clinical pharmacokinetics of factor VIII in patients with classic haemophilia.

Authors:  A Messori; G Longo; M Matucci; M Morfini; P L Ferrini
Journal:  Clin Pharmacokinet       Date:  1987-12       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.